Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Disease Progression and DMD[original query] |
|---|
| SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 2011 Jan 76 (3): 219-26. Pegoraro E, Hoffman E P, Piva L, Gavassini B F, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati M D, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney J M, McDonald C M, |
Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.
Annals of neurology 2018 Jul . Weiss Robert B, Vieland Veronica J, Dunn Diane M, Kaminoh Yuuki, Flanigan Kevin M, |
| Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine 2019 7 98 (26): e15858. Alfano Lindsay N, Charleston Jay S, Connolly Anne M, Cripe Linda, Donoghue Cas, Dracker Robert, Dworzak Johannes, Eliopoulos Helen, Frank Diane E, Lewis Sarah, Lucas Karin, Lynch Jessie, Milici A J, Flynt Amy, Naughton Emily, Rodino-Klapac Louise R, Sahenk Zarife, Schnell Frederick J, Young G David, Mendell Jerry R, Lowes Linda |
| Longitudinal natural history in young boys with Duchenne muscular dystrophy. Neuromuscular disorders : NMD 2019 10 29 (11): 857-862. Coratti Giorgia, Brogna Claudia, Norcia Giulia, Ricotti Valeria, Abbott Lianne, D'Amico Adele, Berardinelli Angela, Vita Gian Luca, Lucibello Simona, Messina Sonia, Sansone Valeria, Albamonte Emilio, Colia Giulia, Salmin Francesca, Gardani Alice, Manzur Adnan, Main Marion, Baranello Giovanni, Arnoldi Maria Teresa, Parsons Julie, Carry Terri, Connolly Anne M, Bertini Enrico, Muntoni Francesco, Pane Marika, Mercuri Eugen |
| TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy. European journal of human genetics : EJHG 2020 Jan . Spitali Pietro, Zaharieva Irina, Bohringer Stefan, Hiller Monika, Chaouch Amina, Roos Andreas, Scotton Chiara, Claustres Mireille, Bello Luca, McDonald Craig M, Hoffman Eric P, , Koeks Zaida, Eka Suchiman H, Cirak Sebahattin, Scoto Mariacristina, Reza Mojgan, 't Hoen Peter A C, Niks Erik H, Tuffery-Giraud Sylvie, Lochmüller Hanns, Ferlini Alessandra, Muntoni Francesco, Aartsma-Rus Annemie |
| Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial. Journal of neuromuscular diseases 2021 Jun . McDonald Craig M, Shieh Perry B, Abdel-Hamid Hoda Z, Connolly Anne M, Ciafaloni Emma, Wagner Kathryn R, Goemans Nathalie, Mercuri Eugenio, Khan Navid, Koenig Erica, Malhotra Jyoti, Zhang Wenfei, Han Baoguang, Mendell Jerry R, |
| Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy. BMC neurology 2022 5 22 (1): 162. Zamani Gholamreza, Hosseinpour Sareh, Ashrafi Mahmoud Reza, Mohammadi Mahmoud, Badv Reza Shervin, Tavasoli Ali Reza, Akbari Masood Ghahvechi, Bereshneh Ali Hosseini, Malamiri Reza Azizi, Heidari Morte |
| Clinical and genetic characteristics of Chinese Duchenne/Becker muscular dystrophy patients with small mutations. Frontiers in neuroscience 2022 11 16 992546. Gan Siyi, Liu Shulei, Yang Haiyan, Wu Liw |
| Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular Dystrophy. Pediatric cardiology 2022 1 43 (4): 855-867. Gambetta Katheryn E, McCulloch Michael A, Lal Ashwin K, Knecht Kenneth, Butts Ryan J, Villa Chet R, Johnson Jonathan N, Conway Jennifer, Bock Matthew J, Schumacher Kurt R, Law Sabrina P, Friedland-Little Joshua M, Deshpande Shriprasad R, West Shawn C, Lytrivi Irene D, Wittlieb-Weber Carol |
- Page last reviewed:Feb 1, 2024
- Content source: